A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
OHSU Knight Cancer Institute
Maastricht Radiation Oncology
Second Life Therapeutics
University of Chicago
AccSalus Biosciences, Inc.
University of California, San Francisco
CHU de Quebec-Universite Laval
Ankara University
Zhejiang University
James J. Peters Veterans Affairs Medical Center